BMRN

Biotech Stocks to bet on: Northwest Biotherapeutics, Inc (NASDAQ …

Investors have been flocking to biotech stocks this year, with the IBB, the ETF that tracks biotech stocks, making noteworthy gains. So far in 2015, several industries have either underperformed or provided mixed results, leading to a rather ho-hum showpiece for U.S. blue-chip indices.Biotech stocks, on the other hand, have consistently returned positive results in the markets over the past […]

Biotech Stocks: Safe vs Sexy – Stocks to Watch – Barrons.com

By Johanna BennettDo you want safe, or sexy?That’s the question facing biotechnology investors, according to a recent research note from Cowen analysts that previews the sector’s second-quarter financial results.“In heady times, large cap provides a safe haven, smid caps the sex appeal,” reads the note.After shrugging off a selloff in late June, the Nasdaq Biotechnology index has gained 30% since […]

No, the Biotech Boom Isn’t Over

By Ben LevisohnRBC’s Michael Yee and team aren’t too worried about biotech stocks like Gilead Sciences (GILD), Celgene (CELG), and Biogen Idec (BIIB) despite the biotech sector’s big drop last week:
Biotech felt another volatile pullback (similar to March) in the last week of April, pulling back 9% in a week. Investors had their helmets on as we went right through […]

BioMarin Weathers The Storm | Benzinga

In last week’s Benzinga article on InterMune (NASDAQ: ITMN), some of the warning signs for the overall stock market were highlighted.Those warnings became more than just warnings last week, as the market took some significant hits. Last Thursday’s 300-plus drop on the Dow Jones Industrial Average was the main headline.Since then the market has continued to decline, but some stocks […]

BioMarin to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference on May 14th and the UBS Global Healthcare Conference on May 20th

[GlobeNewswire] – SAN RAFAEL, Calif. — BioMarin Pharmaceutical Inc. , a global leader in the development and commercialization of therapies for rare genetic diseases, today announced that Dan Spiegelman, Executive Vice … moreView todays social media effects on BMRNView the latest stocks trending across Twitter. Click to view dashboardSee who BioMarin is hiring next, click here to view […]

BioMarin Pharmaceutical’s CEO Discusses Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Jean-Jacques Bienaime Thank you, Traci, and good afternoon and thank you for joining us on today’s call. We had a very productive first quarter led by the U.S. approval and launch of VIMIZIM and very strong … moreView todays social media effects on BMRNView the latest stocks trending across Twitter. Click to view dashboardSee who BioMarin […]